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1. Introduction 
Metabolic syndrome (MS), that has received increased attention in the past few years, 
consists of multiple, interrelated risk factors of metabolic origin that appear to directly 
promote the development of atherosclerotic cardiovascular disease (ASCVD). Most 
important of these underlying risk factors are abdominal obesity and insulin resistance. 
Other associated conditions include physical inactivity, aging, hormonal imbalance, and 
genetic or ethnic predisposition 1. 
The measurement of abdominal obesity through waist circumference (WC) has been 
established as a simple, inexpensive and useful method for the diagnosis of abdominal 
obesity. Thus, WC has been proposed as a key element for the diagnosis of MS and its use 
suggested as a part of the routine general physical examination in clinical practice2. 
Moreover, WC correlates with visceral obesity, and in clinical studies, it has been associated 
with increased cardiovascular risk3. It has been proposed as a part of the routine general 
physical examination in clinical practice.  
It is shown that mesenteric fat thickness is an independent determinant of metabolic 
syndrome, with an odds ratio of 1.35 for every 1 mm increase, at least within the observed 
range of mesenteric fat thickness. The discriminating cut-off point of 10 mm indicates the 
presence of metabolic syndrome and identifies subjects with increased intima-media 
thickness4.  
Hypotheses relating central adiposity to the metabolic syndrome focus on the newly 
emerging understanding that adipose tissue (particularly visceral adipose tissue) is a source 
of factors [including free fatty acids, tumour necrosis factor-alpha (TNF-α)] that impair 
insulin action in skeletal muscle. In addition, the adipose specific collagen-like molecule, 
adiponectin, has been found to have antidiabetic, anti-atherosclerotic and anti-inflammatory 
 Insulin Resistance 230 
functions. Excessive adipose tissue is associated with a decreased production of adiponectin 
which may impair insulin sensitivity.  
Measurement of mesenteric fat thickness may potentially be developed into an alternative 
tool to identify subjects at risk for cardiovascular diseases5. 
Newer clinical studies showed that WC not always correlates with visceral obesity and 
associated risk for cardiovascular diseases in clinical studies6. Therefor, several imaging 
methods have been proposed for estimation of visceral adipose tissue. Recent advances in 
imaging techniques and an understanding of differences in the molecular biology of the 
different adipose tissue depots have been reported. Computed tomography (CT) and 
especially Magnetic Resonance Imaging (MRI), the gold standard technique, provide non 
invasive estimation of VAT (visceral adipose tissue) amount safely and accurately. 
Unfortunately, both MRI and CT are high-cost technologies, and CT requires radiation 
exposure. In addition, a great variability in the precise definition of adipose tissue 
compartments by CT and MRI measurements is found in clinical studies. The measurement 
of visceral fat volume using ultrasonography (US) could calculate as effective as using CT. 
This method should be practiced in clinics due to its low cost, no side effects and technical 
suitability7,8. 
2. Computed tomography 
In 1999, Yoshizumi et al. presented the standard technique for fat visceral fat measurement 
at CT which is used in all further published studies9. CT (TCT-900S Helix; Toshiba, Tokyo, 
Japan) was performed with all subjects supine (120 kV, 200 mA, section thickness of 5 mm, 
scanning time of 2 seconds, field of view of 400 mm). In subjects, subcutaneous and visceral 
fat areas were measured on one cross-sectional scan obtained at the umbilicus. A region of 
interest of the subcutaneous fat layer was defined by tracing its contour on each scan, and 
the attenuation range of CT numbers (in Hounsfield units) for fat tissue was calculated. A 
histogram for fat tissue was computed on the basis of mean attenuation plus or minus 2 SD. 
Intraperitoneal tissue was defined by tracing its contour on the scan; within that region of 
interest, tissue with attenuation within the mean plus or minus 2 SD was considered to be 
the visceral fat area. The pixels with attenuation values in the selected attenuation range 
were depicted as white. From those white regions, the total fat area was calculated by 
counting the number of pixels in each; the visceral fat area was subtracted, and the 
remainder was defined as the subcutaneous fat area. Results with this method were 
compared to those with a computerized planimetric method (KL 4300 Digitizer; Graphtec, 
Tokyo) and with a fixed attenuation range from 2190 to 230 HU as the standard of reference. 
3. Magnetic Resonance Imaging 
The basic method of visceral fat measurement by MR is as described by Demerath et al10. 
Images were obtained with a Magnetom Vision 1.5 Tesla whole-body scanner (Siemens, 
Mississauga, Canada) using a T1-weighted fast-spin echo pulse sequence (TR 322 ms, TE 
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12 ms). The subjects were instructed to lie in the magnet in a supine position with arms 
extended above the head. A breath-hold sequence (≈22 s per acquisition) was used to 
minimize the effects of respiratory motion on the images. All images were acquired on a 256 
× 256 mm matrix and a 480-mm field of view. Slice thickness was 10 mm, and images were 
obtained every 10 mm from the 9th thoracic vertebra (T9) to the first sacral vertebra (S1). 
Depending on the height of the person, this resulted in a total of 21–40 axial images per 
person. The images were retrieved from the scanner according to a DICOM (Digital Imaging 
and Communications in Medicine) protocol (National Electrical Manufacturer’s Association, 
Rosslyn, VA). Segmentation of the axial images into VAT and subcutaneous adipose tissue 
(SAT) areas was performed by 2 trained observers using image analysis software (Slice-O-
Matic, version 4.2; Tomovision Inc, Montreal, Canada). Tagging of adipose tissue began at 
the first image, containing the upper margin of the liver and continued down to the L5-S1 
image, which increased the likelihood that all intraabdominal adipose tissue was included 
in the estimate. To calculate VAT and SAT volumes, the VAT and SAT areas for each image 
were summed across all images. A significant advantage of the contiguous image approach 
is that no geometrical assumptions have to be made regarding how to interpolate between 
consecutive slices for the calculation of total volumes. 
4. Ultrasonography 
Ultrasonography (US) is a simple and reliable method for measuring both subcutaneous and 
visceral fat showing a strong correlation with both adiposities measured with computed 
tomography scan11.  
Different techniques are presented by different authors, and no standard method of 
measurement is still proposed.  
In 1990. Armellini et al.12 proposed the use of ultrasonography for the first time for the 
quantification of visceral adiposity as an alternative technique to CT.  
There are several proposed techniques, but the most reliable technique of ultrasonographic 
measurement of fat tissue thickness was presented by Meriño-Ibarra et al.13. Sonography 
measurements were performed using a linear-array probe (Aloka SSD-900, Tokyo, Japan) 
(7.5 MHz and 42 mm) in supine position. It was kept perpendicular to the skin on the upper 
median abdomen, and longitudinal scan was done in the midpoint between the xiphoid 
appendix and the navel along the alba line with regard to the surface of the liver, to be 
almost parallel to the skin. Subcutaneous fat thickness (STh) and area (SA) were measured 
on the xiphoumbilical line in both longitudinal and transverse views. Measurements were 
taken 3 times directly from the screen using the electronic calipers at the inner edge of the 
skin and at the outer edge of the alba line and the fat-muscle interfaces for area. 
Preperitoneal fat thickness or visceral-fat thickness (VTh) and area (VA) were measured in 
the same sites and views (Fig. 1). In this case, measurements were taken at the inner edge of 
the alba line and at the peritoneal line for thickness and area. Then mean values were 
calculated. Preperitoneal circumference (PC) was calculated as: 
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2( )PC WC STh    
This measurement assumes that WC is a circumference, hence after measuring WC and STh, 
the intra-abdominal radius and PC can be easily calculated with the formula cited 
previously. All the subjects were asked to hold their breath during the examination. Special 
care was taken to keep the probe just touching the skin to prevent compression of the fat 
layers. 
 
Figure 1. Subcutaneous and visceral fat thickness measurement 
Other authors, as well contributed to this topic, Suzuki et al.14 proposed a new index as a 
good non/invasive indicator of viscerl fat deposition. They calculated the abdominal wall fat 
index as preperitoneal fat/subcutaneous fat ratio. The thickness of subcutaneous as 
preperitoneal fat layers was measured directly on the screen using electronic callipers. The 
maximum thickness of preperitoneal fat and the minimum thickness of subcutaneous fat 
were used as representative markers.  
Hirooka et al.15 proposed an another technique. This group measured the distance between 
the internal surface of the abdominal muscle and splenic vein, the distance between the 
internal surface of the abdominal muscle and the posterior wall of the aorta of the aorta on 
the umbilicus and the thickness of the posterior right renal wall in the right posterior 
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perinephritic space. A 3.5MHz convex-array probe was used to measure each 
parameter,other than the thickness of both the subcutaneous and the preperitoneal fat layers 
at the xyphoid process by performing a longitudinal scan, which was measured using 
7.5MHz linear-array probe. The transducer was placed vertically against the skin as lightly 
as possible to prevent compression of the fat layers. The distance between the internal 
surface of the abdominal muscle and the splenic vein was scanned transversely in the 
midline. When the splenic vein could not be visualized clearly, this vein was detected by 
using color Doppler flow. The equation was calculated as follows: 
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There was a good correlation between the visceral fat volume calculated by the above 
equation and the volume by CT described. 
Visceral fat amount can be estimated by measurement of perirenal fat, as presented by 
Kawasaki et al.16. This group performed sonography using a Power Vision 8000 scanner 
(Toshiba, Tokyo, Japan) equipped with a 3.75-MHz convex probe. On sonography, the 
thickness of combined para- and perirenal fat was measured between the kidney and the 
inner aspect of the abdominal musculature. Measurements on both sides were averaged. 
The results correlated with CT measurement, as well as with laboratory values.  
5. Conclusion 
Since 1990, CT has been proposed as the gold standard method to quantify abdominal 
adiposity17. Despre´s and Lamarche18 observed that a visceral fat area of 130 cm2 was 
associated with a high risk of cardiovascular events, although prospective studies are still 
lacking to confirm such an association. In the meantime, other techniques have been used to 
predict cardiovascular risk. Undoubtedly, BMI is the most common method for estimating 
body fat, and several epidemiological studies have reinforced its role in the prediction of 
morbidity and mortality19,20. However, an increased BMI does not show which body 
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compartment (fat or lean mass) is inadequate and cannot differentiate subcutaneous from 
visceral fat accumulation. The use of US in the assessment of intra-abdominal fat, initially 
proposed by Armellini et al.12, was further confirmed by strong correlations with the CT-
determined visceral fat area14,21. US is expected to be the most specific method because it 
allows the individual visualization of subcutaneous and intra-abdominal (visceral) fat. In 
addition, US is a noninvasive and quick method with good reproducibility rates (intra-
examination variation <1%) and lower costs than CT scans. However, specific equipment 
and a welltrained examiner are required. Despite the fact that body composition might be 
attributable to ethnic differences, changes in the US-determined visceral-to-subcutaneous fat 
ratio can potentially be monitored for the risk associated with visceral fat accumulation. 
Also, US may represent a useful method for monitoring weight loss, variations in visceral 
fat, and associated risks22.  
Whatever technique is used, ultrasonography is a reliable method for measurement visceral 
fat amount and assessment of metabolic syndrome presence and risk for cardiovascular 
diseases development. 
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